ZA200705363B - Pharmaceutical compositions comprising amorphous benzimidazole compounds - Google Patents
Pharmaceutical compositions comprising amorphous benzimidazole compoundsInfo
- Publication number
- ZA200705363B ZA200705363B ZA200705363A ZA200705363A ZA200705363B ZA 200705363 B ZA200705363 B ZA 200705363B ZA 200705363 A ZA200705363 A ZA 200705363A ZA 200705363 A ZA200705363 A ZA 200705363A ZA 200705363 B ZA200705363 B ZA 200705363B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- benzimidazole compounds
- amorphous benzimidazole
- amorphous
- compounds
- Prior art date
Links
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1401CH2004 | 2004-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200705363B true ZA200705363B (en) | 2008-08-27 |
Family
ID=36602289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200705363A ZA200705363B (en) | 2004-12-20 | 2007-07-02 | Pharmaceutical compositions comprising amorphous benzimidazole compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20080146615A1 (xx) |
| EP (1) | EP1827429A4 (xx) |
| CA (1) | CA2591983A1 (xx) |
| RU (1) | RU2007123436A (xx) |
| WO (1) | WO2006069159A2 (xx) |
| ZA (1) | ZA200705363B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI289557B (en) * | 1999-06-17 | 2007-11-11 | Takeda Chemical Industries Ltd | A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
| EP1830822A1 (en) * | 2004-12-24 | 2007-09-12 | LEK Pharmaceuticals D.D. | Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| US7553857B2 (en) * | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
| US20090068263A1 (en) * | 2006-04-20 | 2009-03-12 | Themis Laboratories Private Limited | Multiple unit compositions |
| US8055291B2 (en) * | 2007-09-12 | 2011-11-08 | Telefonaktiebolaget Lm Ericsson (Publ) | Power-aware link adaptation in a wideband CDMA system |
| KR101104349B1 (ko) * | 2007-09-28 | 2012-01-16 | 주식회사 씨티씨바이오 | 에소메프라졸 함유 약학 조성물 |
| US20110177164A1 (en) * | 2008-10-06 | 2011-07-21 | Gopal Rajan | Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof |
| EP2663306A4 (en) * | 2011-01-12 | 2014-01-01 | Hetero Research Foundation | POLYMORPHS OF DEXLANSOPRAZOLE SALTS |
| CN112601606A (zh) * | 2018-08-30 | 2021-04-02 | 勃林格殷格翰国际有限公司 | 新颖、精益且环境友好的制粒方法 |
| CN109771396B (zh) * | 2019-03-05 | 2022-02-08 | 深圳市新阳唯康科技有限公司 | 一种含奥美拉唑的口腔膜剂及其制备方法 |
| JP7606825B2 (ja) * | 2020-06-15 | 2024-12-26 | 東和薬品株式会社 | エソメプラゾール顆粒ならびにその製造方法および用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
| PT854718E (pt) * | 1995-09-21 | 2004-08-31 | Pharma Pass Ii Llc | Composicao farmaceutica contendo um benzimidazole acido-labil e processo para a sua preparacao |
| ATE364374T1 (de) * | 1997-08-11 | 2007-07-15 | Pfizer Prod Inc | Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit |
| US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| DE19918434A1 (de) * | 1999-04-23 | 2000-10-26 | Basf Ag | Feste Pharmazeutische Formulierungen von säurelabilen Protonenpumpenblockern |
| CA2290893C (en) * | 1999-11-16 | 2007-05-01 | Bernard Charles Sherman | Magnesium omeprazole |
| CA2409258A1 (en) * | 2000-05-15 | 2001-11-22 | Ranbaxy Laboratories Limited | Novel amorphous form of omeprazole salts |
| WO2003000294A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer |
| WO2003000235A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| AU2002346472A1 (en) * | 2001-11-20 | 2003-06-10 | Advanced Inhalation Research, Inc. | Particulate compositions for improving solubility of poorly soluble agents |
| AU2003273000A1 (en) * | 2002-10-16 | 2004-05-04 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
| US20040235903A1 (en) * | 2002-10-22 | 2004-11-25 | Khanna Mahavir Singh | Amorphous form of esomeprazole salts |
| EP1845982A2 (en) * | 2005-02-02 | 2007-10-24 | Ranbaxy Laboratories Limited | Stable oral benzimidazole compositions prepared by non-aqueous layering process |
-
2005
- 2005-12-20 CA CA002591983A patent/CA2591983A1/en not_active Abandoned
- 2005-12-20 RU RU2007123436/15A patent/RU2007123436A/ru not_active Application Discontinuation
- 2005-12-20 EP EP05855020A patent/EP1827429A4/en not_active Withdrawn
- 2005-12-20 WO PCT/US2005/046393 patent/WO2006069159A2/en not_active Ceased
- 2005-12-20 US US11/722,247 patent/US20080146615A1/en not_active Abandoned
-
2007
- 2007-07-02 ZA ZA200705363A patent/ZA200705363B/xx unknown
-
2009
- 2009-09-03 US US12/553,409 patent/US20090324728A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090324728A1 (en) | 2009-12-31 |
| CA2591983A1 (en) | 2006-06-29 |
| WO2006069159A3 (en) | 2006-12-21 |
| EP1827429A4 (en) | 2009-08-05 |
| US20080146615A1 (en) | 2008-06-19 |
| EP1827429A2 (en) | 2007-09-05 |
| RU2007123436A (ru) | 2009-01-27 |
| WO2006069159A2 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223545A0 (en) | Pharmaceutical compositions | |
| ZA200700030B (en) | Pharmaceutical compositions | |
| GB0408308D0 (en) | Pharmaceutical compositions | |
| ZA200804305B (en) | Pharmaceutical compositions comprising buprenorphine | |
| ZA200705363B (en) | Pharmaceutical compositions comprising amorphous benzimidazole compounds | |
| IL189929A0 (en) | Novel dosage formulation | |
| IL188352A0 (en) | Pharmaceutical compositions | |
| PT1725218E (pt) | Composição farmacêutica compreendendo pimobendano | |
| ZA200804103B (en) | Pharmaceutical compositions | |
| PL1837019T3 (pl) | Kompozycja farmaceutyczna rozpadająca się w ustach | |
| IL192091A0 (en) | Pharmaceutical compositions | |
| EP1805154A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0522045D0 (en) | Pharmaceutical compositions | |
| GB0407351D0 (en) | Pharmaceutical compositions | |
| EP1845944A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0400971D0 (en) | Pharmaceutical compositions | |
| GB0422582D0 (en) | Pharmaceutical compositions | |
| GB0411502D0 (en) | Pharmaceutical compositions | |
| ZA200803566B (en) | Pharmaceutical compositions | |
| GB0514259D0 (en) | Pharmaceutical compositions | |
| GB0425728D0 (en) | Pharmaceutical compositions | |
| GB0420173D0 (en) | Pharmaceutical compositions | |
| GB0422572D0 (en) | Pharmaceutical compositions | |
| GB0412733D0 (en) | Pharmaceutical compositions | |
| GB0412562D0 (en) | Pharmaceutical compositions |